Many MS Patients in Britain Missing Out on Recommended Treatment

by Kathy Jones on  April 29, 2013 at 7:34 PM Drug News
RSS Email Print This Page Comment bookmark
Font : A-A+

A new survey carried out by MS Society in Britain has found that just two in five patients who are eligible for multiple sclerosis drugs are taking them.
 Many MS Patients in Britain Missing Out on Recommended Treatment
Many MS Patients in Britain Missing Out on Recommended Treatment

Over 10,000 multiple sclerosis patients took part in the survey with the researchers finding that majority of the patients were missing on seven licensed medicines approved for treating MS.

The researchers added that one of the major reasons for patients not taking the drugs was the lack of information and access to specialists and added that the government should come out with a personalized care plan to every person with MS.

"This could be due to barriers to accessing medicines; because individuals make an informed decision not to take them; or because they don't know what information is out there that they could have access to, such as around new treatments or new evidence of efficacy", the researchers wrote in their report.

Source: Medindia

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor
Advertisement

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive